[Federal Register Volume 67, Number 225 (Thursday, November 21, 2002)]
[Notices]
[Page 70218]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-29588]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Patent Application Concerning Protective Peptides of 
Neurotoxin of C. Botulinum

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6 and 404.7, announcement is 
made of the availability for licensing of U.S. Patent No. 6,287,566 
entitled ``Protective Peptides of Neurotoxin of C. Botulinum,'' issued 
September 11, 2001 and related U.S. Patent Application No. 09/917,791 
entitled ``Protective Peptides of Neurotoxin of C. Botulinum,'' filed 
July 31, 2001. The United States Government, as represented by the 
Secretary of the Army, has rights in this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664, both 
at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: Methods for developing vaccines to protect 
from neurotoxins of C. botulinum have been developed. Truncated BoNT/A 
proteins of about 15-30 kDa in size produced immune responses that 
provided protection from neuronal damage by botulinum neurotoxins.

Luz D. Ortiz,
Army Federal Register Liaison Officer.
[FR Doc. 02-29588 Filed 11-20-02; 8:45 am]
BILLING CODE 3710-08-M